{
  "catalogId": "f5a4d160-8b34-4d51-bc83-996aae309c75",
  "name": "VITRAKVI  100 MG",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "164 41 36178 00",
  "treatmentDescriptions": "Vitrakvi as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a Neurotrophic Tyrosine Receptor Kinase (NTRK) gene fusion:• Who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and• Who have no satisfactory treatment options",
  "termsOfIssue": "Prescription required",
  "form": "capsules",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "LAROTRECTINIB AS SULFATE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01XE53",
      "name": "LAROTRECTINIB"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "VITRAKVI  20 MG/ML ORAL SOLUTION 100ML",
      "manufacturer": {
        "name": "באייר",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 100.0,
        "unit": "units"
      },
      "packagingDescription": "BOTTLE HDPE",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "8737",
        "yarpa": "14797"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 8051.36334,
        "retailMargin": 10.0,
        "maxRetailPrice": 8856.499674,
        "maxPriceWithVAT": 10450.66915
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-07-31T22:09:13.838549"
  }
}